Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection-Reference-Cited by-同舟云学术

Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection

Published:2015-11-11 Issue:11 Volume:10 Page:e0140909
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Noordeen Faseeha,Scougall Catherine A.,Grosse Arend,Qiao Qiao,Ajilian Behzad B.,Reaiche-Miller Georget,Finnie John,Werner Melanie,Broering Ruth,Schlaak Joerg F.,Vaillant Andrew,Jilbert Allison R.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. The cost of managing chronic hepatitis B infection: a global perspective;KV Kowdley;J. Clin. Gastroenterol.,2004

2. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B;TT Chang;N. Engl. J. Med.,2006

3. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B;CL Lai;N. Engl. J. Med.,2006

4. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B;P Marcellin;N. Engl. J. Med.,2008

5. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B;GK Lau;N. Engl. J. Med.,2005

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients;Antiviral Research;2024-04

2. Hepatitis delta: recent advances and future therapies;Future Virology;2024-03-23

3. Progress in Treatment and Diagnostics of Infectious Disease with Polymers;ACS Infectious Diseases;2024-01-18

4. Genetic characterization of duck hepatitis B viruses from Anhui Province, China;Brazilian Journal of Microbiology;2023-09-06

5. Rapid monophasic HBsAg decline during nucleic-acid polymer–based therapy predicts functional cure;Hepatology Communications;2023-07-17